Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04208438 · ClinicalTrials.gov registry record
Non-Invasive Jugular Venous Blood Volume Assessment (BVI)
A clinical trial, sponsored by Wayne State University.
- Completed
- Registry status
- 50
- Enrollment target
NCT04208438: Completed study, sponsored by Wayne State University.
NCT04208438 is a clinical trial that has completed, run by Wayne State University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04208438 has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the ability of the Mespere Blood Volume Index (BVI) device to calculate the blood volume in the jugular veins by comparing the measurements from the device to volumetric measurements obtained with ultrasound.
Primary Outcome
Comparison of measurement of blood volume in jugular vein using BVI and POCUS
Interventions
- DIAGNOSTIC_TEST BVI Device
- DIAGNOSTIC_TEST Point-of-Care Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-06-05 |
| Est. Completion | 2019-10-07 |
What the finished NCT04208438 record still lists
NCT04208438 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which BVI Device is the first listed.
NCT04208438 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04208438 about?
NCT04208438 is a clinical study titled "Non-Invasive Jugular Venous Blood Volume Assessment (BVI)". The purpose of this study is to evaluate the ability of the Mespere Blood Volume Index (BVI) device to calculate the blood volume in the jugular veins by comparing the measurements from the device to volumetric measurements obtained with ultrasound.
What is the current status of trial NCT04208438?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2019-06-05. Estimated completion is 2019-10-07.
What interventions are being tested in trial NCT04208438?
The interventions under investigation include: BVI Device (DIAGNOSTIC_TEST), Point-of-Care Ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04208438?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI